Home / Resource Library / Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell LeukemiaVemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia